New Serotype 2 and Attenuated Serotype 1 Marek's Disease Vaccine Viruses: Comparative Efficacy

R. L. Witter

doi:10.2307/1591027

journal article Oct 01, 1987

New Serotype 2 and Attenuated Serotype 1 Marek's Disease Vaccine Viruses: Comparative Efficacy

R. L. Witter

Avian Diseases Vol. 31 No. 4 pp. 752 · American Association of Avian Pathologists (AAAP)

View at Publisher Save 10.2307/1591027

Topics

No keywords indexed for this article. Browse by subject →

Cited By

54

Comparative Molecular Characterization of Three Gallid alphaherpesvirus Type 3 Strains 301B/1, HPRS24, and SB-1

Taejoong Kim, Jeremy D. Volkening · 2020

Avian Diseases

Vaccinal efficacy of molecularly cloned Gallid alphaherpesvirus 3 strain 301B/1 against very virulent Marek’s disease virus challenge

Taejoong Kim, Stephen J. Spatz · 2020

Journal of General Virology

Cell culture attenuation eliminates rMd5ΔMeq-induced bursal and thymic atrophy and renders the mutant virus as an effective and safe vaccine against Marek's disease

Lucy F. Lee, Mohammad Heidari · 2012

Vaccine

Metrics

54

Citations

0

References

Details

Published: Oct 01, 1987
Vol/Issue: 31(4)
Pages: 752

Authors

R

R. L. Witter

Cite This Article

R. L. Witter (1987). New Serotype 2 and Attenuated Serotype 1 Marek's Disease Vaccine Viruses: Comparative Efficacy. Avian Diseases, 31(4), 752. https://doi.org/10.2307/1591027

New Serotype 2 and Attenuated Serotype 1 Marek's Disease Vaccine Viruses: Comparative Efficacy

You May Also Like